APA-viite

Asangani, I. A., Wilder-Romans, K., Dommeti, V. L., Krishnamurthy, P. M., Apel, I. J., Escara-Wilke, J., . . . Chinnaiyan, A. M. (2016). BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer. Mol Cancer Res.

Chicago-tyylinen lähdeviittaus

Asangani, Irfan A., et al. "BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer." Mol Cancer Res 2016.

MLA-viite

Asangani, Irfan A., et al. "BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer." Mol Cancer Res 2016.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.